Answers are grounded in this paper and cite their sources.
This study suggests that increased levels of certain systemic inflammatory markers, including interleukin 1β and interleukin 17A, during pregnancy were associated with adverse birth outcomes and infant growth deficits. Future studies should evaluate whether potential interventions to modulate specific inflammatory pathways during pregnancy could improve birth outcomes and infant growth.
No takes yet. Share an insight, caveat, or question.
Shafiq et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: